Shareholders' Equity and Share Based Compensation - Additional Information (Detail) - USD ($)		12 Months Ended
	Sep. 10, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Aug. 09, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Net proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)	9,396,226
Issued and sold of common shares		91,788,929	88,233,929
Description of units sold	Each unit that was sold consisted of one common share of the Company and one-half (0.5) of a warrant to purchase a common share of the Company
Class of warrant or right, exercise price of warrants or rights	$ 5.80
Warrants exercisable beginning date	Mar. 10, 2021
Warrants exercisable expiration date	Sep. 10, 2025
Number of warrants exercised		3,188,680
Option granted contractual term		10 years
Stock options vesting period		3 years	3 years
Weighted average grant date fair value		$ 3.31	$ 6.00	$ 4.65
Aggregate Intrinsic value exercised		$ 772,000	$ 2,273,000	$ 2,732,000
Unrecognized share based compensation expense		$ 5,692,000
Share based compensation cost expected period for recognition		3 years
Share based compensation expense		$ 3,987,000	$ 7,533,000	$ 6,142,000
Sales Agreement [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Issued and sold of common shares		3,175,000
Proceeds from issuance of common stock after deducting commissions and offering expenses		$ 6,692,000
Sales Agreement [Member] | Maximum [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Common shares aggregate offering price					$ 50,000,000
Stock Compensation Plan [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Maximum percentage of outstanding shares		10.00%
Number of shares available for issuance		5,069